Teva Pharmaceutical Industries Ltd. - Did you know that 4.5 to 5.9 million Americans suffer from a severe form of #asthma called #eosinophilic asthma? Learn more about the condition in this infographic! #WorldAsthmaDay | Facebook
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
FDA Approves Teva's ProAir Digihaler for Asthma, COPD | RT
Salamol 100micrograms/dose Easi-Breathe inhaler (Teva UK Ltd) 200 dose - RightBreathe
FDA approves Teva's asthma drug Cinqair - Philadelphia Business Journal
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society
Teva launches asthma social media campaign - PMLiVE
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round | Fierce Pharma
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva's DuoResp Spiromax wins silver at MDEA
Teva launches connected inhaler for asthma, COPD - Drug Delivery Business
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Releases AirDuo RespiClick plus Generic for Asthma | RT
Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness | Fierce Pharma
Teva buys Gecko to add device and app to asthma and COPD drugs
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Buying Proair HFA Generic Salbutamol - Asthma Inhalers from Canada
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma
Teva Pharmaceuticals on Twitter: "This month is National Asthma and Allergy Awareness Month and identifying and avoiding #asthma triggers is an important part of asthma management. Read and learn more here: https://t.co/CkL08njkXr #
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
